BDBM253922 US9464092, N::US9527857, N

SMILES: O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(cn3)N3CCC(CC3)N3CCCCC3)nc21

InChI Key: InChIKey=VYYVSGBSHKYYPS-UHFFFAOYSA-N

Data: 6 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 253922   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Cyclin-Dependent Kinase 4 (CDK4) (Homo sapiens (Human))	BDBM253922 (US9464092, N | US9527857, N) Show SMILES O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(cn3)N3CCC(CC3)N3CCCCC3)nc21 Show InChI InChI=1S/C29H38N8O/c38-27-24-17-21-18-31-28(34-26(21)37(24)29(20-32-27)11-3-1-4-12-29)33-25-8-7-23(19-30-25)36-15-9-22(10-16-36)35-13-5-2-6-14-35/h7-8,17-19,22H,1-6,9-16,20H2,(H,32,38)(H,30,31,33,34)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
G1 Therapeutics, Inc. US Patent					Assay Description Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....				US Patent US9464092 (2016) BindingDB Entry DOI: 10.7270/Q28C9V5W
					More data for this Ligand-Target Pair
CDK2/CycE (Homo sapiens (Human))	BDBM253922 (US9464092, N | US9527857, N) Show SMILES O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(cn3)N3CCC(CC3)N3CCCCC3)nc21 Show InChI InChI=1S/C29H38N8O/c38-27-24-17-21-18-31-28(34-26(21)37(24)29(20-32-27)11-3-1-4-12-29)33-25-8-7-23(19-30-25)36-15-9-22(10-16-36)35-13-5-2-6-14-35/h7-8,17-19,22H,1-6,9-16,20H2,(H,32,38)(H,30,31,33,34)	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
G1 Therapeutics, Inc. US Patent					Assay Description Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK6/CycD3 CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif....				US Patent US9464092 (2016) BindingDB Entry DOI: 10.7270/Q28C9V5W
					More data for this Ligand-Target Pair
Cyclin-Dependent Kinase 4 (CDK4) (Homo sapiens (Human))	BDBM253922 (US9464092, N | US9527857, N) Show SMILES O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(cn3)N3CCC(CC3)N3CCCCC3)nc21 Show InChI InChI=1S/C29H38N8O/c38-27-24-17-21-18-31-28(34-26(21)37(24)29(20-32-27)11-3-1-4-12-29)33-25-8-7-23(19-30-25)36-15-9-22(10-16-36)35-13-5-2-6-14-35/h7-8,17-19,22H,1-6,9-16,20H2,(H,32,38)(H,30,31,33,34)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
GI Therapeutics, Inc. US Patent					Assay Description Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...				US Patent US9527857 (2016) BindingDB Entry DOI: 10.7270/Q2MK6B2C
					More data for this Ligand-Target Pair
Cyclin-Dependent Kinase 4 (CDK4) (Homo sapiens (Human))	BDBM253922 (US9464092, N | US9527857, N) Show SMILES O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(cn3)N3CCC(CC3)N3CCCCC3)nc21 Show InChI InChI=1S/C29H38N8O/c38-27-24-17-21-18-31-28(34-26(21)37(24)29(20-32-27)11-3-1-4-12-29)33-25-8-7-23(19-30-25)36-15-9-22(10-16-36)35-13-5-2-6-14-35/h7-8,17-19,22H,1-6,9-16,20H2,(H,32,38)(H,30,31,33,34)	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1	n/a	n/a	n/a	n/a	n/a	n/a
GI Therapeutics, Inc. US Patent					Assay Description Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...				US Patent US9527857 (2016) BindingDB Entry DOI: 10.7270/Q2CN72V8
					More data for this Ligand-Target Pair
CDK2/CycE (Homo sapiens (Human))	BDBM253922 (US9464092, N | US9527857, N) Show SMILES O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(cn3)N3CCC(CC3)N3CCCCC3)nc21 Show InChI InChI=1S/C29H38N8O/c38-27-24-17-21-18-31-28(34-26(21)37(24)29(20-32-27)11-3-1-4-12-29)33-25-8-7-23(19-30-25)36-15-9-22(10-16-36)35-13-5-2-6-14-35/h7-8,17-19,22H,1-6,9-16,20H2,(H,32,38)(H,30,31,33,34)	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
GI Therapeutics, Inc. US Patent					Assay Description Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...				US Patent US9527857 (2016) BindingDB Entry DOI: 10.7270/Q2MK6B2C
					More data for this Ligand-Target Pair
CDK2/CycE (Homo sapiens (Human))	BDBM253922 (US9464092, N | US9527857, N) Show SMILES O=C1NCC2(CCCCC2)n2c1cc1cnc(Nc3ccc(cn3)N3CCC(CC3)N3CCCCC3)nc21 Show InChI InChI=1S/C29H38N8O/c38-27-24-17-21-18-31-28(34-26(21)37(24)29(20-32-27)11-3-1-4-12-29)33-25-8-7-23(19-30-25)36-15-9-22(10-16-36)35-13-5-2-6-14-35/h7-8,17-19,22H,1-6,9-16,20H2,(H,32,38)(H,30,31,33,34)	PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	1.50E+3	n/a	n/a	n/a	n/a	n/a	n/a
GI Therapeutics, Inc. US Patent					Assay Description Selected compounds disclosed herein were tested in CDK4/cyclinD1, CDK2/CycA and CDK2/cyclinE kinase assays by Nanosyn (Santa Clara, Calif.) to determ...				US Patent US9527857 (2016) BindingDB Entry DOI: 10.7270/Q2CN72V8
					More data for this Ligand-Target Pair